These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4368116

  • 1. [Effects of aminoglutethimide on cortisol secretion in Cushing's disease].
    Boyer J, Valette A, Latrabe J, Codaccioni JL.
    Ann Endocrinol (Paris); 1973; 34(5):519-26. PubMed ID: 4368116
    [No Abstract] [Full Text] [Related]

  • 2. [Cushing's syndrome].
    Geyer G.
    Ann N Y Acad Sci; 1973 Jun 15; 214():614-9. PubMed ID: 4593436
    [No Abstract] [Full Text] [Related]

  • 3. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE, Conn JW.
    J Clin Endocrinol Metab; 1967 Dec 15; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract] [Full Text] [Related]

  • 4. [A case of Cushing's disease treated by aminoglutethimide].
    Thevenet M, Lumbroso P, Netter A.
    Ann Endocrinol (Paris); 1968 Dec 15; 29(3):346-50. PubMed ID: 4326387
    [No Abstract] [Full Text] [Related]

  • 5. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M, Allolio B, Jaursch-Hancke C, Kaulen D, Winkelmann W.
    Dtsch Med Wochenschr; 1987 Oct 02; 112(40):1532-5. PubMed ID: 2820688
    [Abstract] [Full Text] [Related]

  • 6. Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.
    Hermus AR, Pieters GF, Smals AG, Pesman GJ, Lamberts SW, Benraad TJ, van Haelst UJ, Kloppenborg PW.
    N Engl J Med; 1988 Apr 14; 318(15):966-70. PubMed ID: 2832758
    [No Abstract] [Full Text] [Related]

  • 7. [Use of aminoglutethimide in a case of Cushing's syndrome due to ectopic ACTH production].
    Neri V, Schieppati G, Rondena M, Cozzi C.
    Clin Ter; 1977 Oct 31; 83(2):163-73. PubMed ID: 201424
    [No Abstract] [Full Text] [Related]

  • 8. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
    Marova EI, Lemesheva SN.
    Probl Endokrinol (Mosk); 1970 Oct 31; 16(5):7-10. PubMed ID: 5520275
    [No Abstract] [Full Text] [Related]

  • 9. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW, Juselius R, Hanlon J, Steed D.
    Clin Chem; 1973 Sep 31; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of metopyrone on the levels of ACTH and 11-HCS in the plasma and the excretion of individual 17-HCS and 17-KS in Itsenko-Cushing disease].
    Marova EI, Lemesheva SN, Makarovskaia EE, Fedoseeva GI, Starkova NT.
    Probl Endokrinol (Mosk); 1972 Sep 31; 18(3):7-12. PubMed ID: 4337678
    [No Abstract] [Full Text] [Related]

  • 11. Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Pan CY, Luo GC, Li JY, Wang YZ, Lu SZ, Ma SQ, Guo AY.
    Chin Med J (Engl); 1989 Nov 31; 102(11):890-4. PubMed ID: 2561555
    [Abstract] [Full Text] [Related]

  • 12. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF, Burke CW, Burley DM, Rees LH, Fraser TR.
    Acta Endocrinol (Copenh); 1976 Jun 31; 82(2):330-41. PubMed ID: 179256
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Hunter PR, Ross W, Hall R, Cook DB.
    Proc R Soc Med; 1974 Dec 31; 67(12 Pt 1):1225. PubMed ID: 4375290
    [No Abstract] [Full Text] [Related]

  • 14. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B, Gaggini M, Secchi F, Faglia G.
    Horm Metab Res; 1979 Apr 31; 11(4):318-9. PubMed ID: 222663
    [No Abstract] [Full Text] [Related]

  • 15. Is it possible to diagnose pituitary-dependent Cushing's disease?
    Howlett TA, Rees LH.
    Ann Clin Biochem; 1985 Nov 31; 22 ( Pt 6)():550-8. PubMed ID: 3000267
    [No Abstract] [Full Text] [Related]

  • 16. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL, Lee KO, Cheah JS.
    Singapore Med J; 1992 Oct 31; 33(5):523-4. PubMed ID: 1455284
    [Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW, Beardwell CG.
    Q J Med; 1973 Jan 31; 42(165):175-204. PubMed ID: 4688791
    [No Abstract] [Full Text] [Related]

  • 18. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Thorén M, Adamson U, Sjöberg HE.
    Acta Endocrinol (Copenh); 1985 Aug 31; 109(4):451-7. PubMed ID: 3898689
    [Abstract] [Full Text] [Related]

  • 19. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug 31; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 20. Severe osteopenia in young adults associated with Cushing's syndrome due to micronodular adrenal disease.
    Ruder HJ, Loriaux DL, Lipsett MB.
    J Clin Endocrinol Metab; 1974 Dec 31; 39(6):1138-47. PubMed ID: 4372247
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.